PTPN2 deletions, which result in aberrant activation of the PI3K-AKT-mTOR pathway, have specifically been observed in T-ALL cases with aberrant expression of TLX1 and have a similar incidence in pediatric and adult cohorts [15, 102]. Here, TLX1 is linked to acute lymphoblastic leukemia.